Symphony builds health research group with Source deal
Source will be combined with STG’s pharma market research company ImpactRX, which acquired AlphaDetail and TargetRX last year to form Symphony Health Solutions. Within this group, Source will be focused on providing analytics for life science manufacturers, payers and providers.
STG said that it plans to integrate the companies within the healthcare group “over time” with the aim of offering joint value propositions for clients. Bob Jansen and Michelle Woker will remain with Source as president of commercial and president of operations respectively.
Woker (pictured) said: “Bringing together Source’s secondary data assets with ImpactRx’s proprietary syndicated data set and analytical and therapeutic expertise will enable our combined new company to deliver the comprehensive, multi-channel solutions our clients need.”
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments